Your browser doesn't support javascript.
loading
Multimeric scaffolds displaying the HIV-1 envelope MPER induce MPER-specific antibodies and cross-neutralizing antibodies when co-immunized with gp160 DNA.
Krebs, Shelly J; McBurney, Sean P; Kovarik, Dina N; Waddell, Chelsea D; Jaworski, J Pablo; Sutton, William F; Gomes, Michelle M; Trovato, Maria; Waagmeester, Garret; Barnett, Susan J; DeBerardinis, Piergiuseppe; Haigwood, Nancy L.
Afiliação
  • Krebs SJ; Division of Pathobiology and Immunology, Oregon National Primate Research Center, Oregon Health and Sciences University, Beaverton, OR, United States of America.
  • McBurney SP; Division of Pathobiology and Immunology, Oregon National Primate Research Center, Oregon Health and Sciences University, Beaverton, OR, United States of America.
  • Kovarik DN; Viral Vaccines Program, Seattle Biomedical Research Institute, Seattle, WA, United States of America.
  • Waddell CD; Division of Pathobiology and Immunology, Oregon National Primate Research Center, Oregon Health and Sciences University, Beaverton, OR, United States of America.
  • Jaworski JP; Division of Pathobiology and Immunology, Oregon National Primate Research Center, Oregon Health and Sciences University, Beaverton, OR, United States of America.
  • Sutton WF; Division of Pathobiology and Immunology, Oregon National Primate Research Center, Oregon Health and Sciences University, Beaverton, OR, United States of America.
  • Gomes MM; Division of Pathobiology and Immunology, Oregon National Primate Research Center, Oregon Health and Sciences University, Beaverton, OR, United States of America.
  • Trovato M; Institute of Protein Biochemistry, C.N.R., Naples, Italy.
  • Waagmeester G; Division of Pathobiology and Immunology, Oregon National Primate Research Center, Oregon Health and Sciences University, Beaverton, OR, United States of America.
  • Barnett SJ; Novartis Vaccines & Diagnostics, Emeryville, CA, United States of America.
  • DeBerardinis P; Institute of Protein Biochemistry, C.N.R., Naples, Italy.
  • Haigwood NL; Division of Pathobiology and Immunology, Oregon National Primate Research Center, Oregon Health and Sciences University, Beaverton, OR, United States of America; Viral Vaccines Program, Seattle Biomedical Research Institute, Seattle, WA, United States of America.
PLoS One ; 9(12): e113463, 2014.
Article em En | MEDLINE | ID: mdl-25514675
Developing a vaccine that overcomes the diversity of HIV-1 is likely to require a strategy that directs antibody (Ab) responses toward conserved regions of the viral Envelope (Env). However, the generation of neutralizing Abs (NAbs) targeting these regions through vaccination has proven to be difficult. One conserved region of particular interest is the membrane proximal external region (MPER) of Env located within the gp41 ectodomain. In order to direct the immune response to this region, the MPER and gp41 ectodomain were expressed separately as N-terminal fusions to the E2 protein of Geobacillus stearothermophilus. The E2 protein acts as a scaffold by self-assembling into 60-mer particles, displaying up to 60 copies of the fused target on the surface. Rabbits were immunized with E2 particles displaying MPER and/or the gp41 ectodomain in conjunction with DNA encoding full-length gp160. Only vaccines including E2 particles displaying MPER elicited MPER-specific Ab responses. NAbs were elicited after two immunizations that largely targeted the V3 loop. To overcome V3 immunodominance in the DNA component, E2 particles displaying MPER were used in conjunction with gp160 DNA lacking hypervariable regions V2, V3, or combined V1V2V3. All rabbits had HIV binding Ab responses and NAbs following the second vaccination. Using HIV-2/HIV-1 MPER chimeric viruses as targets, NAbs were detected in 12/16 rabbits after three immunizations. Low levels of NAbs specific for Tier 1 and 2 viruses were observed in all groups. This study provides evidence that co-immunizing E2 particles displaying MPER and gp160 DNA can focus Ab responses toward conserved regions of Env.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: HIV-1 / Vacinas contra a AIDS / Proteína gp160 do Envelope de HIV / Anticorpos Neutralizantes / Anticorpos Antivirais Limite: Animals Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: HIV-1 / Vacinas contra a AIDS / Proteína gp160 do Envelope de HIV / Anticorpos Neutralizantes / Anticorpos Antivirais Limite: Animals Idioma: En Ano de publicação: 2014 Tipo de documento: Article